Exaggerated effect of fluvoxamine in heterozygote serotonin transporter knockout mice

Journal of Neurochemistry

Volumn 86, Issue 1, 2003, Pages 210-219

  Montañez, Sylvia ^a   Owens, W Anthony ^a   Gould, Georgianna G ^b   Murphy, Dennis L ^c   Daws, Lynette C ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Chronoamperometry; Hippocampus; Norepinephrine transporter; Serotonin clearance rates; Serotonin transporter; Serotonin transporter knockout mice

Indexed keywords

DESIPRAMINE; FLUVOXAMINE; NORADRENALIN; PSYCHOTROPIC AGENT; SEROTONIN; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR;

AMPEROMETRY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DRUG CLEARANCE; DRUG EFFECT; EXTRACELLULAR FLUID; GENE DISRUPTION; GENE TARGETING; HETEROZYGOTE; HIPPOCAMPUS; KNOCKOUT MOUSE; MALE; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; POTENTIOMETRY; PRIORITY JOURNAL; SEROTONINERGIC TRANSMISSION; SYNAPTOSOME;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; BINDING, COMPETITIVE; CARRIER PROTEINS; DESIPRAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; FLUVOXAMINE; HETEROZYGOTE; HIPPOCAMPUS; HOMOZYGOTE; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; SYMPORTERS;

ANIMALIA;

EID: 17144466384     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01836.x     Document Type: Article

References (39)

1. Bengel D., Murphy D. L., Andrews A. M., Wichems C. H., Feltner D., Heils A., Mossner R., Westphal H. and Lesch K.-P. (1998) Altered brain serotonin (5-HT) homeostasis and locomotor insensitivity to MDMA ('ectasy') in 5-HT transporter-deficient mice. Mol. Pharmacol. 53, 649-655.
2. Benmansour S., Cecchi M., Morilak D. A., Gerhardt G. A., Javors M. A., Gould G. G. and Frazer A. (1999) Effects of chronic antidepressant treatments on serotonin transporter function, density and mRNA level. J. Neurosci. 19, 10494-14501.
3. Benmansour S., Owens W. A., Cecchi M., Morilak D. A. and Frazer A. (2002) Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced down-regulation of the serotonin transporter than by acute blockade of this transporter. J. Neurosci. 22, 6766-6772.
4. Blakely R. D., Ramamoorthy S., Schroeter S., Qian Y., Apparsundaram S., Galli A. and DeFelice L. J. (1998) Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol. Psychiatry 44, 169-178.
5. Codd E. E. and Walker R. F. (1987) Platelet serotonin uptake: methods and strain differences. Psychiatry Res. 22, 61-67.
6. Daws L. C., Toney G. M., Davis D. J., Gerhardt G. A. and Frazer A. (1997) In vivo chronoamperometric measurements of the clearance of exogenously applied serotonin in rat dentate gyrus. J. Neurosci. Meth. 78, 139-150.
7. Daws L. C., Toney G. M., Gerhardt G. A. and Frazer A. (1998) In vivo chronoamperometric measures of extracellular serotonin clearance in rat dorsal hippocampus: contribution of serotonin and norepinephrine transporters. J. Pharmacol. Exp. Ther. 286, 967-976.
8. 1B receptor-mediated regulation of serotonin clearance in rat hippocampus in vivo. J. Neurochem. 75, 2113-2122.
9. Daws L. C., Montañez S., Gould G. G., Gerhardt G. A. and Frazer A. (2000b) In vivo kinetics of serotonin clearance is dependent on brain region and density of serotonin and norepinephrine transporters. Soc. Neurosci. Abstr. 26, 1668.
10. Fedele D. E., Matthews T. A., Mamounas L. A., Lyons W. E. and Andrews A. M. (2001) Quantitative microdialysis for serotonin in the striatum and frontal cortex of genetically altered mice, in Monitoring Molecules in Neuroscience. Proceedings of the 9th International Conference on In Vivo Methods (O'Connor W. T., Lowry J. P., O'Connor J. J. and O'Neill R. D., eds), pp. 97-98. University College Dublin, Dublin.
11. Franklin K. B. J. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, Sydney.
12. Gobbi G., Murphy D. L., Lesch K.-P. and Blier P. (2001) Modifications of the serotonergic system in mice lacking serotonin transporters: An in vivo electrophysiological study. J. Pharmacol. Exp. Ther. 296, 897-995.
13. Heils A., Teufel A., Petri S., Stoeber G., Riederer P., Bengel D. and Lesch K.-P. (1996) Allelic variation of human serotonin transporter gene expression. J. Neurochem. 66, 2621-2624.
14. Hoffman A. and Gerhardt G. A. (1998) In vivo electrochemical studies of dopamine clearance in the rat substantia nigra: effects of locally applied uptake inhibitors and unilateral 6-hydroxydopamine lesions. J. Neurochem. 70, 179-189.
15. Holmes A., Yang R. J., Murphy D. L. and Crawley J. N. (2002) Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter. Neuropsychopharmacology 27, 914-923.
16. Jackson B. P., Dietz S. M. and Wightman R. M. (1995) Fast-scan cyclic voltammetry of 5-hydroxtryptamine. Anal. Chem. 67, 1115-1120.
17. Jones S. R., Gainetdinov R. R., Jaber M., Giros B., Wightman R. M. and Caron M. G. (1998) Profound neural plasticity in response to inactivation of the dopamine transporter. Proc. Natl Acad. Sci. 95, 4029-4034.
18. Kelsoe J. R. (1998) Promoter prognostication: the serotonin transporter gene and antidepressant response. Mol. Psychiatry 3, 475-476.
19. Kim D. K., Lim S. W., Lee S., Sohn S. E., Kim S., Hahn C. G. and Carroll B. J. (2000) Serotonin transporter gene polymorphism and antidepressant response. Neuroreport 11, 215-219.
20. 3H]-cyanoimipramine. Brain Res. 454, 78-88.
21. Lesch K.-P., Bengel D., Heils A., Sabol S. Z., Greenberg B. D., Petri S., Benjamin J., Muller C. R., Hamer D. H. and Murphy D. L. (1996) Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 274, 1527-1153.
22. Mannoury la Cour C., Boni C., Hanoun N., Lesch K.-P., Hamon M. and Lanfumey L. (2001) Functional consequences of 5-HT transporter gene disruption on 5-HT1A receptor-mediated regulation of dorsal raphe and hippocampal cell activity. J. Neurosci. 21, 2178-2185.
23. Masson J., Sagné C., Hamon M. and El Mestikawy S. (1999) Neurotransmitter transporters in the central nervous system. Pharmacol. Rev. 51, 439-464.
24. Montañez S., Daws L. C., Gould G. G., Gerhardt G. A. and Frazer A. (2002) Differential in vivo clearance of serotonin in rat dorsal raphe nucleus and CA3 region. Brain Res. 955, 236-244.
25. Mundo E., Walker M., Cate T., Macciardi F. and Kennedy J. L. (2001) The role of the serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder. Arch. Gen. Psychiatry 58, 539-544.
26. Near J. A., Bigelow J. C. and Wightman R. M. (1988) Comparison of uptake of dopamine in rat striatal chopped tissue and synaptosomes. J. Pharmacol. Exp. Ther. 245, 921-927.
27. Nicholson C. (1995) Interaction between diffusion and Michaelis-Menten uptake of dopamine after iontopboresis in striatum. Biophys. J. 68, 1699-1715.
28. Nicholson C. and Syková E. (1998) Extracellular space structure revealed by diffusion analysis. Trends Neurosci. 21, 207-215.
29. Perez X. A. and Andrews A. M. (2000) 5-HT reuptake in SERT knockout mice by chronoamperometry, in Serotonin: from the Molecule to the Clinic. Abstracts, A Serotonin Club/Brain Res. Bull. Conference, p124.
30. Ramamoorthy S., Giovanetti E., Qian Y. and Blakely R. D. (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J. Biol. Chem. 273, 2458-2466.
31. Rausch J. L., Johnson M. E., Fei Y. J., Li J. Q., Shendarkar N., Hobby H. M., Ganapathy V. and Leibach F. H. (2002) Initial conditions of serotonin transporter kinetics and genotype: influence on SSRI treatment trial outcome. Biol. Psychiat. 51, 723-732.
32. Sabeti J., Gerhardt G. A. and Zahniser N. R. (2002) Acute cocaine differentially alters accumbens and striatal dopamine clearance in low and high cocaine locomotor responders: behavioral and electrochemical recordings in freely moving rats. J. Pharmacol. Exp. Ther. 302, 1201-1211.
33. Shaskan E. G. and Snyder S. H. (1970) Kinetics of serotonin accumulation into slices from rat brain: relationship to catecholamine uptake. J. Pharmacol. Exp. Ther. 175, 404-418.
34. Smeraldi E., Zanardi R., Benedetti F., Di Bella D., Perez J. and Catalano M. (1998) Polymorphism within the serotonin transporter and antidepressant efficacy of fluvoxamine. Mol. Psychiatry 3, 508-511.
35. 3H]-nisoxetine: a radioligand for quantitation of norepinephrine uptake sites by autoradiography of homogenate binding. J. Pharmacol. Exp. Ther. 260, 427-436.
36. Van Horne C., Hoffer B. J., Stromberg I. and Gerhardt G. A. (1992) Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat Striatum. J. Pharmacol. Exp. Ther. 263, 1285-1292.
37. Whale R., Quested D. J., Laver D., Harrison P. J. and Cowen P. J. (2000) Serotonin transporter (5-HTT) promoter genotype may influence the prolactin response to clomipramine. Psychopharmacology 150, 120-122.
38. Whitworth T. L., Herndon L. C. and Quick M. W. (2001) Psychostimulants differentially regulate serotonin transporter expression in thalamocortical neurons. J. Neurosci. 21, 1-6.
39. Zanardi R., Benedetti F., Di Bella D., Catalano M. and Smeraldi E. (2000) Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J. Clin. Psychopharmacol. 20, 105-107.